Navigation Links
MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
Date:1/25/2012

KENNESAW, Ga., Jan. 25, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that they will be attending the American Academy of Orthopaedic Surgeons (AAOS) annual meeting, February 8 through February 10, 2012. The AAOS 2012 annual meeting will be held at the Moscone Center in San Francisco, California. 

MiMedx will be presenting the Company's biomaterial platform technologies developed for use in soft tissue trauma, nerve repair, spinal applications and sports medicine. During the conference, MiMedx will be presenting HydroFix®, one its device technologies, and AmnioFix®, one of is tissue technologies, and highlighting the Company's offerings, AmnioFix® Injectable and AmnioFix® Wrap.

Throughout the conference, MiMedx plans to sponsor various meetings with physicians and scientists to discuss and demonstrate the benefits and potential of these offerings. MiMedx Group will be located in Booth 2309 at the Moscone Center. 

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion™ process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 60,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
4. MiMedx Groups Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering
5. MiMedx Group Announces Second Quarter 2011 Results
6. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
7. MiMedx Group Completes $5,000,000 Private Placement
8. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
9. MiMedx Group Announces First Quarter 2011 Results
10. MiMedx Group Announces 2010 Results
11. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media ... in 2017 and Beyond. The paper outlines the key trends that are creating ... , “We’ve witnessed a lot of highs and lows as the precision agriculture ...
(Date:5/23/2016)... May 23, 2016 - Leading CRO,s Use ... - Frontage Implement a Single Platform to Manage End-to-end Operations ... Within the Bioanalytical lab Frontage Laboratories, a full-service contract ... and China , has selected IDBS, ... In addition to serving as the global electronic lab notebook (ELN), ...
(Date:5/22/2016)... (PRWEB) , ... May 22, 2016 , ... Doctors in ... in combating the asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article ... in the University of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more ...
(Date:5/20/2016)... ... ... Korean researchers say Manumycin A triggers apoptosis, or natural cell death, in ... disease. Surviving Mesothelioma has just posted an article on the new study. Click ... mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces parvulus, is ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):